|
Aurobindo Pharma slides after USFDA classifies Eugia Unit-III as OAI> |
|
Aurobindo Pharma Ltd leads losers in 'A' group> |
|
Aurobindo Pharma's Eugia Unit-III receives OAI classification from USFDA> |
|
Aurobindo Pharma gains after receiving USFDA approval for Tofacitinib tablets> |
|
Aurobindo Pharma receives USFDA approval for Tofacitinib Tablets> |
|
USFDA classifies Eugia Pharma Specialities' Telangana unit inspection as Official Action Indicated> |
|
Aurobindo Pharma consolidated net profit rises 1.97% in the March 2026 quarter> |
|
Suraksha Diagnostic Ltd Falls 7.95%> |
|
Aurobindo Pharma Ltd up for third consecutive session> |
|
CuraTeQ Biologics receives CDSCO marketing authorisation for Bevqolva®> |